Australia's most trusted
source of pharma news
Friday, 3 July 2026
Friday, 3 July 2026
Subscribe
Login
Pharma Wonderland opens in Sydney
An Australian family-owned pharmaceutical manufacturer has officially opened a $250 million plant called Wonderland set to become the biggest facility of its kind in the Southern Hemisphere.
Where next for six Country Heads?
ICYMI: Some of industry's biggest names are between jobs. Find out who plus the other most popular stories this week
TODAY Your Week in 5 Minutes
Pharmas cut spend on patients
The latest MA transparency report reveals pharma's financial support to patient organisations, has dropped year-on-year
TODAY
Next era of blockbusters unveiled
The top 10 best-selling drugs for 2032 have been named. Find out who's risen up the rankings and who's vanished...
2 July
Media frenzy bites AstraZeneca
A global decision to wind back a monthly hormone blocker has seen AstraZeneca Australia come under sustained fire in the media
2 July
Did this pharma disparage a rival?
The European Commission has opened an antitrust investigation to assess if this pharma campaign disparaged a rival
2 July
Butler fails to rule out PBS delisting
Dept calls for savage price cuts to two major drugs that treat almost half the Aussie patients suffering from MS
1 July
Latest Jobs
Customer Service AdministratorClinical Trial InvestigatorCustomer Service RepresentativeWarehouse AssistantInside Sales SpecialistInside Sales SpecialistInside Sales SpecialistCustomer Service Representative39 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (26)
- Customer Service Administrator - East Ryde
- Customer Service Representative - Warriewood
- Inside Sales Specialist - Melbourne
- Inside Sales Specialist - Sydney
- Inside Sales Specialist - Brisbane
- Customer Service Representative - Perth
- Customer Service Representative - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Auckland
- Customer Service Representative - Melbourne
- Customer Service Representative - Macquarie Park
- Territory Manager - Sydney
- Territory Manager - Sterilisation - Melbourne
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
Access & Reimbursement (2)
- Head of Access, Sustainability & External Engagement - Melbourne
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
Clinical & Medical, R&D (7)
- Clinical Trial Investigator - Melbourne
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (6)
- Regulatory Affairs Manager - Belrose
- Senior Quality Assurance Associate - Randwick
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
Executive Roles (5)
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Director - Regulatory Affairs - Melbourne
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
Other (9)
Haemophilia market heats up
A pegged blockbuster has been approved by the TGA with the company 'working with urgency' to ensure equitable access
TODAY
Gamechanger stumps cost experts
Worth the cost? Nobody knows and patients are missing out because health systems can't accurately assess its cost-effectiveness
TODAY
TGA asking about radio pathways
Consultation opens on how pharmas experience regulatory pathways for radiopharmaceuticals in the real world
2 July
Top names lead closed-door event
Three well-known industry execs fronted a panel to discuss outsourcing as an increasingly important strategic growth lever
2 July
Cancer patients pick No. 1 pharma
Companies selected for best corporate reputation but industry overall scolded for failing to improve access to innovative medicines
1 July
July PBS listings climb to 13
Find out who the Health Minister forgot to mention in his PBS announcement as more companies celebrate good news
1 July New to the PBS
Agency sold for undisclosed sum
Acquisition further expands the company's medical and market access capabilities and strengthens its global presence
1 July
Half left uncovered by PBS
Patients Australia survey finds people are often prescribed drugs not covered by the PBS with many delaying treatment due to cost
1 July
Government expands vax funding
Data showing previously ineligible groups are at risk has prompted an expansion of the funded vaccine programs
1 July
Troubled drug faces revocation
Concerns over a registrational trial have seen overseas authorities recommend removing approval for this PBS-listed drug
30 June
Six Aussie Country Leaders in limbo
A spate of departures from country leadership roles across ANZ has left six top operators in limbo and a number of job openings
30 June
J&J argues against 'far greater evil'
The pharma giant is seeking clarification on the size of a class action suit against it, while the applicants argue it would just produce 'useless information'
30 June
'Policy lag tax' hurting patients
The true cost of policy delays is costing patients and the payment due is far more expensive than cash dollars
30 June
TGA win lands just in time
This company has earned the regulator's nod for a drug which will be considered by the PBAC when it meets early next month
30 June